Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
923.85
705.05
624.61
554.19
893.51
697.31
756.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
923.85
705.05
624.61
554.19
893.51
697.31
756.39
Raw Material Cost
60.27
45.84
60.85
49.73
41.80
45.08
51.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.99
0.00
0.08
3.96
2.85
2.41
2.58
Selling and Distribution Expenses
535.63
406.47
385.48
324.24
539.77
413.71
458.31
Other Expenses
1.01
0.38
1.01
0.08
0.38
-0.05
0.58
Total Expenditure (Excl Depreciation)
607.97
456.16
456.47
378.70
588.21
460.76
518.21
Operating Profit (PBDIT) excl Other Income
315.9
248.9
168.1
175.5
305.3
236.6
238.2
Other Income
27.40
54.92
119.11
15.80
41.36
116.18
108.67
Operating Profit (PBDIT)
361.10
303.81
306.10
209.90
365.08
371.20
164.64
Interest
1.99
0.00
0.08
3.96
2.85
2.41
2.58
Exceptional Items
0.60
-1.42
-14.95
0.34
-2.24
-2.13
-207.86
Gross Profit (PBDT)
863.58
659.21
563.76
504.46
851.71
652.22
704.89
Depreciation
18.44
0.00
18.61
18.61
18.47
18.47
8.64
Profit Before Tax
341.27
302.39
272.46
187.66
349.25
348.19
-54.43
Tax
35.13
31.40
7.33
17.89
37.59
32.20
-3.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
298.04
269.28
259.42
168.73
310.22
312.92
-54.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
298.04
269.28
259.42
168.73
310.22
312.92
-54.43
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.50
0.97
2.51
0.33
0.62
2.32
1.15
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
300.54
270.25
261.93
169.06
310.84
315.24
-53.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,161.11
4,101.03
3,917.82
3,629.96
3,791.72
3,659.32
3,344.59
Earnings per share (EPS)
0.92
0.84
0.8
0.52
0.96
0.97
-0.17
Diluted Earnings per share
0.92
0.84
0.8
0.52
0.96
0.97
-0.17
Operating Profit Margin (Excl OI)
34.12%
35.3%
26.96%
31.67%
34.16%
33.92%
6.26%
Gross Profit Margin
38.94%
42.89%
46.6%
37.22%
41.15%
52.58%
-6.05%
PAT Margin
32.26%
38.19%
41.53%
30.45%
34.72%
44.88%
-7.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 31.05% vs 12.87% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 11.21% vs 3.17% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 34.07% vs 33.10% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Tibet Rhodiola Pharmaceutical Holding Co. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
923.85
0
923.85
Other Operating Income
0.00
0.00
0.00
Total Operating income
923.85
0
923.85
Raw Material Cost
60.27
0
60.27
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.99
0
1.99
Selling and Distribution Expenses
535.63
0
535.63
Other Expenses
1.01
0.00
1.01
Total Expenditure (Excl Depreciation)
607.97
0
607.97
Operating Profit (PBDIT) excl Other Income
315.88
0.00
315.88
Other Income
27.40
0
27.40
Operating Profit (PBDIT)
361.10
0
361.10
Interest
1.99
0
1.99
Exceptional Items
0.60
0
0.60
Gross Profit (PBDT)
863.58
0
863.58
Depreciation
18.44
0
18.44
Profit Before Tax
341.27
0
341.27
Tax
35.13
0
35.13
Provisions and contingencies
0
0
0.00
Profit After Tax
298.04
0
298.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
298.04
0
298.04
Share in Profit of Associates
0
0
0.00
Minority Interest
2.50
0
2.50
Other related items
0.00
0.00
0.00
Consolidated Net Profit
300.54
0
300.54
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,161.11
0
4,161.11
Earnings per share (EPS)
0.92
0
0.92
Diluted Earnings per share
0.92
0
0.92
Operating Profit Margin (Excl OI)
34.12%
0%
0.00
34.12%
Gross Profit Margin
38.94%
0%
0.00
38.94%
PAT Margin
32.26%
0%
0.00
32.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 92.39 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 31.05% vs 12.87% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 3.40% vs -1.05% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 30.05 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 11.21% vs 3.17% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -3.31% vs 5.61% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.37 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 34.07% vs 33.10% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 3.09% vs -4.71% in Jun 2024
Quarterly - Interest
Interest 0.20 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -28.57% vs 75.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.12%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
